Industry News
Nosopharm and Evotec Enter into Collaboration to Accelerate Development of Novel Antibiotics
New partnership to advance Nosopharm’s lead candidate to clinical stage
New partnership to advance Nosopharm’s lead candidate to clinical stage
NOSO-502 on track to be the first novel antibiotic class to be introduced into the clinics for 40 years
Exciting new discovery describes the mechanism of action of a new class of antibiotics